A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
Oxidized phospholipids (OxPLs) on apolipoprotein B-100 (apoB-100) particles are strongly associated with lipoprotein [a] (Lp[a]). In this study, we evaluated whether Lp[a] is preferentially the carrier of OxPL in human plasma. The content of OxPL on apoB-100 particles was measured with monoclonal an...
| Published in: | Journal of Lipid Research |
|---|---|
| Main Authors: | Claes Bergmark, Asheesh Dewan, Alexina Orsoni, Esther Merki, Elizabeth R. Miller, Min-Jeong Shin, Christoph J. Binder, Sohvi Hörkkö, Ronald M. Krauss, M. John Chapman, Joseph L. Witztum, Sotirios Tsimikas |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2008-10-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520346460 |
Similar Items
Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study
by: James L. Januzzi, et al.
Published: (2024-06-01)
by: James L. Januzzi, et al.
Published: (2024-06-01)
Effect of lipid-lowering medications on oxidized phospholipids in individuals with elevated LIPOPROTEIN(a)
by: Amalia Despoina Koutsogianni, et al.
Published: (2025-09-01)
by: Amalia Despoina Koutsogianni, et al.
Published: (2025-09-01)
Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease
by: Tiffany R. Bellomo, et al.
Published: (2024-07-01)
by: Tiffany R. Bellomo, et al.
Published: (2024-07-01)
Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)
by: Santica M. Marcovina, et al.
Published: (2022-08-01)
by: Santica M. Marcovina, et al.
Published: (2022-08-01)
ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
by: Edward B. Neufeld, et al.
Published: (2019-07-01)
by: Edward B. Neufeld, et al.
Published: (2019-07-01)
Bioinspired Lipoproteins of Furoxans–Gemcitabine Preferentially Targets Glioblastoma and Overcomes Radiotherapy Resistance
by: Maoyuan Sun, et al.
Published: (2024-02-01)
by: Maoyuan Sun, et al.
Published: (2024-02-01)
Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi‐Ethnic Study of Atherosclerosis
by: Harpreet S. Bhatia, et al.
Published: (2024-02-01)
by: Harpreet S. Bhatia, et al.
Published: (2024-02-01)
Demographics of lipoprotein(a) and stroke: The UK biobank
by: Andrew S. Kao, et al.
Published: (2025-09-01)
by: Andrew S. Kao, et al.
Published: (2025-09-01)
Extracellular Particles as Carriers of Cholesterol Not Associated with Lipoproteins
by: Sergey Landa, et al.
Published: (2022-06-01)
by: Sergey Landa, et al.
Published: (2022-06-01)
Causal association of lipoprotein-associated phospholipids on the risk of sepsis: a Mendelian randomization study
by: Liying Zeng, et al.
Published: (2024-01-01)
by: Liying Zeng, et al.
Published: (2024-01-01)
The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)
by: E. A. Utkina, et al.
Published: (2019-06-01)
Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a)
by: Ayelet Gonen, et al.
Published: (2020-09-01)
by: Ayelet Gonen, et al.
Published: (2020-09-01)
Comparison of ten formulae for calculating low-density lipoprotein cholesterol with direct low-density lipoprotein cholesterol measurement
by: Suriyan S. Nair, et al.
Published: (2024-10-01)
by: Suriyan S. Nair, et al.
Published: (2024-10-01)
Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)
by: Alexander C. Razavi, et al.
Published: (2024-06-01)
by: Alexander C. Razavi, et al.
Published: (2024-06-01)
Lipoprotein(a) throughout life in women
by: Pablo Corral, et al.
Published: (2024-12-01)
by: Pablo Corral, et al.
Published: (2024-12-01)
ANGPTL3 (Angiopoietin‐Like 3) Preferentially Resides on High‐Density Lipoprotein in the Human Circulation, Affecting Its Activity
by: Jordan M. Kraaijenhof, et al.
Published: (2023-11-01)
by: Jordan M. Kraaijenhof, et al.
Published: (2023-11-01)
Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
by: Kuo-Hsuan Chang, et al.
Published: (2023-01-01)
by: Kuo-Hsuan Chang, et al.
Published: (2023-01-01)
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)
Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021-01-01)
by: Tina Z. Khan, et al.
Published: (2021-01-01)
Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
by: Feroz Ahmad, et al.
Published: (2021-09-01)
by: Feroz Ahmad, et al.
Published: (2021-09-01)
Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
by: Christian Schäfer, et al.
Published: (2007-07-01)
by: Christian Schäfer, et al.
Published: (2007-07-01)
Excessive centrifugal fields damage high density lipoprotein [S]
by: William H. Munroe, et al.
Published: (2015-06-01)
by: William H. Munroe, et al.
Published: (2015-06-01)
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
by: Svetlana Schekatolina, et al.
Published: (2022-07-01)
by: Svetlana Schekatolina, et al.
Published: (2022-07-01)
LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)
by: U. Julius, et al.
Published: (2018-09-01)
Diet-induced and age-related changes in rats: the impact of N-stearoylethanolamine intake on plasma lipoproteins, adiponectin, and adipocyte cholesterol-phospholipid composition
by: O. S. Tkachenko, et al.
Published: (2024-04-01)
by: O. S. Tkachenko, et al.
Published: (2024-04-01)
Hypothyroidism consequent to thyroidectomy is associated with elevated remnant lipoproteins and cholesterol enrichment of triglyceride-rich lipoproteins: an observational study
by: Adrian Post, et al.
Published: (2025-04-01)
by: Adrian Post, et al.
Published: (2025-04-01)
Analyzing the molecular mechanism of lipoprotein localization in Brucella
by: Shivani eGoolab, et al.
Published: (2015-10-01)
by: Shivani eGoolab, et al.
Published: (2015-10-01)
An Efficacy of Seligi Leaf Flour Fermentation on Cholesterol Levels, Low Density Lipoprotein, and High Density Lipoprotein in Catfish
by: Reza Hardiansyah, et al.
Published: (2022-04-01)
by: Reza Hardiansyah, et al.
Published: (2022-04-01)
The role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
by: Malihe Aghasizadeh, et al.
Published: (2020-06-01)
by: Malihe Aghasizadeh, et al.
Published: (2020-06-01)
Impact of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio on the risk factors for and outcome of ischemic stroke
by: Xin-wei BI, et al.
Published: (2014-10-01)
by: Xin-wei BI, et al.
Published: (2014-10-01)
Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia
by: Irani Khatun, et al.
Published: (2013-06-01)
by: Irani Khatun, et al.
Published: (2013-06-01)
Phospholipid biomarkers of coronary heart disease
by: Shin-ya Morita
Published: (2024-05-01)
by: Shin-ya Morita
Published: (2024-05-01)
Approaches to Visualising Endocytosis of LDL-Related Lipoproteins
by: Halima Siddiqui, et al.
Published: (2022-01-01)
by: Halima Siddiqui, et al.
Published: (2022-01-01)
Serum Lipoprotein (A) in Patients with Fibromyalgia Syndrome
by: Mohammed * Hadi Munshed, et al.
Published: (2011-06-01)
by: Mohammed * Hadi Munshed, et al.
Published: (2011-06-01)
High-Density Lipoprotein and Heart Failure
by: Liyun Xing, et al.
Published: (2023-11-01)
by: Liyun Xing, et al.
Published: (2023-11-01)
1H NMR spectroscopy quantifies visibility of lipoproteins, subclasses, and lipids at varied temperatures and pressures
by: Daniela Baumstark, et al.
Published: (2019-09-01)
by: Daniela Baumstark, et al.
Published: (2019-09-01)
Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
by: Mei Dong, et al.
Published: (2025-01-01)
by: Mei Dong, et al.
Published: (2025-01-01)
Case report: lipoprotein apheresis reduces the risk of cardiovascular events and prolongs pregnancy in a woman with severely elevated lipoprotein(a), cardiovascular disease, and a high risk of preeclampsia
by: Joanna Marlȩga-Linert, et al.
Published: (2023-09-01)
by: Joanna Marlȩga-Linert, et al.
Published: (2023-09-01)
Real-world impact of transitioning from one lipoprotein(a) assay to another in a clinical setting
by: Janeni Jeevanathan, et al.
Published: (2024-09-01)
by: Janeni Jeevanathan, et al.
Published: (2024-09-01)
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
by: Anni Kumari, et al.
Published: (2021-07-01)
by: Anni Kumari, et al.
Published: (2021-07-01)
Similar Items
-
Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study
by: James L. Januzzi, et al.
Published: (2024-06-01) -
Effect of lipid-lowering medications on oxidized phospholipids in individuals with elevated LIPOPROTEIN(a)
by: Amalia Despoina Koutsogianni, et al.
Published: (2025-09-01) -
Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease
by: Tiffany R. Bellomo, et al.
Published: (2024-07-01) -
Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)
by: Santica M. Marcovina, et al.
Published: (2022-08-01) -
ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
by: Edward B. Neufeld, et al.
Published: (2019-07-01)
